IL1B and neoplasm: For example, IL-1 is released by effector cells and plays a central role in immune and inflammatory responses in breast cancer, specifically tumor invasion.34 Preclinical studies of treatment with the IL-1 receptor antagonist anakinra promoted significant breast tumor control in mice.